PODCAST
On The Pen With Dave Knapp
Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!
All Episodes
00:45:44
00:45:58
Lower Cost Zepbound and Wegovy? TrumpRX Announcement...
On The Pen With Dave Knapp
·
2025/11/04
en-us
00:23:55
Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide...
On The Pen With Dave Knapp
·
2025/10/30
en-us
00:29:41
Retatrutide + Tirzepatide Grey Market Clampdown + 1...
On The Pen With Dave Knapp
·
2025/10/28
en-us
00:49:48
00:29:33
TRUMP: Ozempic Will Soon be $150 in the US! Meet the...
On The Pen With Dave Knapp
·
2025/10/17
en-us
00:27:44
00:40:26
00:38:01
Sobriety Meets Weight Loss: The Ethan Suplee Interview
On The Pen With Dave Knapp
·
2025/10/07
en-us
01:10:55
Mounjaro Hair Loss + NFL Lineman Discovers Power in...
On The Pen With Dave Knapp
·
2025/10/03
en-us
00:42:24
01:17:07
00:34:13
Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide...
On The Pen With Dave Knapp
·
2025/09/23
en-us
00:50:03
00:44:20
Compound GLP-1 Legislation + FDA Warning Letter to HIMS
On The Pen With Dave Knapp
·
2025/09/16
en-us
00:39:02
FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack...
On The Pen With Dave Knapp
·
2025/09/09
en-us
00:26:01
01:06:26
00:36:00
00:34:01